Dextrothyroxine

Dextrothyroxine

Template:Drugbox Dextrothyroxine (trade name Choloxin) saw research as an cholesterol-lowering drug[1][2] but was pulled due to cardiac side-effects. It also increases hepatic lipase which in turn improves utilization of triglycerides, improving apolipoprotein E cholesterol particles.

See also

References